2007
DOI: 10.1016/j.prp.2007.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Mutations of microsatellite instability target genes in sporadic basal cell carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…These results contrasted to those found in immunocompetent patients where AMLs and (non-Muir-Torre related) SGCs are microsatellite stable (Rimsza et al, 2000;Harwood et al, 2001). As less than 5% of the cutaneous SCCs and BCCs in immunocompetent patients display MSI (Quinn et al, 1995;Gray et al, 2006;Saetta et al, 2007), we hypothesized that cutaneous skin carcinomas of this specific group of patients might display MSI as a result of the azathioprine treatment. This could also be a possible explanation for the higher incidence of SCCs observed in azathioprine-using OTRs compared to OTRs on other drugs (Ulrich and Stockfleth, 2007;Crespo-Leiro et al, 2008).…”
mentioning
confidence: 62%
“…These results contrasted to those found in immunocompetent patients where AMLs and (non-Muir-Torre related) SGCs are microsatellite stable (Rimsza et al, 2000;Harwood et al, 2001). As less than 5% of the cutaneous SCCs and BCCs in immunocompetent patients display MSI (Quinn et al, 1995;Gray et al, 2006;Saetta et al, 2007), we hypothesized that cutaneous skin carcinomas of this specific group of patients might display MSI as a result of the azathioprine treatment. This could also be a possible explanation for the higher incidence of SCCs observed in azathioprine-using OTRs compared to OTRs on other drugs (Ulrich and Stockfleth, 2007;Crespo-Leiro et al, 2008).…”
mentioning
confidence: 62%
“…None of the 141 analyzed skin lesions displayed MSI at any of the assessed markers [ 20 ]. Based on their results and the data reported in previous studies, the authors concluded that MSI-H/dMMR is not a relevant tumorigenic mechanism in non-melanoma skin cancer [ 20 , 21 , 22 ]. By contrast, MSI-H/dMMR might be more relevant in cutaneous melanoma (CM) and its responsiveness to ICI.…”
Section: Discussionmentioning
confidence: 89%
“…However, none of the skin lesions showed MSI-H at any of the assessed markers [ 11 ]. Based on their results and the data reported in the previous studies [ 5 , 6 , 7 , 8 , 9 ], the authors concluded that MSI-H/dMMR is not a relevant tumorigenic mechanism in NMSC [ 9 ]. Young et al [ 12 ] found overexpression of MMR proteins in cSCC when compared to normal epidermis.…”
Section: Discussionmentioning
confidence: 98%
“…However, there exist relatively sparse and conflicting data on MSI-H/dMMR in cutaneous malignancies. Several research groups previously investigated MSI-H in NMSC [ 5 , 6 , 7 , 8 , 9 ], also including 56 cSCC. Notably, 53 (56/94.6%) lesions originated from immunosuppressed patients.…”
Section: Introductionmentioning
confidence: 99%